Cumberland Pharmaceuticals (CPIX) Enterprise Value (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Enterprise Value across 17 years of filings, most recently posting -$11.3 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$11.3 million, up 26.48% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.3 million (up 26.48% YoY), and the FY2025 annual result was -$11.8 million, up 35.52% from the prior year.
• Enterprise Value came in at -$11.3 million for Q1 2026 at Cumberland Pharmaceuticals, up from -$11.8 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$11.3 million in Q1 2026 to a low of -$20.1 million in Q4 2022.
• The 5-year median for Enterprise Value is -$17.8 million (2024), against an average of -$17.2 million.
• Across the five-year window, Enterprise Value fell 12.88% in 2024 and soared 35.52% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Enterprise Value stood at -$20.1 million in 2022, then rose by 6.91% to -$18.7 million in 2023, then climbed by 2.11% to -$18.3 million in 2024, then jumped by 35.52% to -$11.8 million in 2025, then rose by 3.74% to -$11.3 million in 2026.
• The last three Enterprise Value figures came in at -$11.3 million (Q1 2026), -$11.8 million (Q4 2025), and -$15.5 million (Q3 2025), per Business Quant data.